Home›Legal›Ipamorelin in Pennsylvania
Ipamorelin in Pennsylvania: Legal Status & Provider Guide (2026)
Quick Answer
Ipamorelin is a prescription substance in the United States. Ipamorelin is an unapproved research peptide with no FDA bulk compounding authorization. While it has been offered by compounding pharmacies under various interpretations, federal compliance risk is elevated. Patients should verify current regulatory standing with their provider. In Pennsylvania, compounding is governed by the Pennsylvania State Board of Pharmacy (PSBP). Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on the FDA 503A or 503B bulk substances lists. Ipamorelin's compounding status is contested — it was removed from the 503A consideration list and faces similar restrictions to other unapproved peptides.
Compounding Pharmacy Rules (Federal)
Ipamorelin is not on the FDA-approved 503A or 503B bulk substances lists. Some compounding pharmacies have offered it historically, but FDA guidance suggests significant legal risk. Its status is often treated similarly to CJC-1295 and other non-listed peptides. Legal compounding under federal oversight is uncertain.
Also Known As
NNC 26-0161
Primary Research Areas
- Growth hormone stimulation
- Anti-aging
- Body composition
- Recovery
Pennsylvania Pharmacy Board & Compounding Rules
Compounding Overview
Pennsylvania's State Board of Pharmacy regulates compounding pharmacies with detailed sterile and non-sterile compounding standards. Pennsylvania has historically been home to several large-scale compounding operations. The state enforces USP 797 standards for sterile products and requires annual inspections for high-risk compounding. Pennsylvania is part of the northeastern corridor with significant demand from New York, New Jersey, and Delaware markets.
Notable Rules
- Pennsylvania requires pharmacies engaged in sterile compounding to have a separate license category.
- Annual inspections are required for pharmacies performing high-risk sterile compounding.
- Pennsylvania shares regulatory burden with the FDA for pharmacies also registered as 503B outsourcing facilities.
- Non-resident pharmacies shipping compounds into Pennsylvania must be registered with the PSBP.
- Pennsylvania and New York maintain some reciprocal licensing arrangements for pharmacy professionals.
Prescribing Requirements in Pennsylvania
Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
About Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHSR agonist) and a pentapeptide. It stimulates growth hormone release with reportedly high selectivity — less stimulation of cortisol and prolactin than earlier GHRPs. Most evidence comes from animal studies.
For more research information, mechanism of action, and provider availability, see the Ipamorelin research profile on PeptideBase.
Frequently Asked Questions
- Is ipamorelin legally available from compounding pharmacies?
- Ipamorelin is not on the FDA bulk substances lists for 503A or 503B compounding. Some pharmacies have offered it, but federal compliance is uncertain. The regulatory environment has tightened since 2021. Patients should ask their provider for explicit documentation of the legal basis.
Ipamorelin Providers in Pennsylvania
No providers currently listed in Pennsylvania for Ipamorelin. Browse the full directory to find providers offering Ipamorelin.
Browse all Ipamorelin providers →Ipamorelin Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare Ipamorelin legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .